Expert consensus on vaccination in patients with inflammatory bowel disease in Japan.

Publisher: Springer International Country of Publication: Japan NLM ID: 9430794 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-5922 (Electronic) Linking ISSN: 09441174 NLM ISO Abbreviation: J Gastroenterol Subsets: MEDLINE

Original Publication: Tokyo : Springer International, c1994-

COVID-19* ; Inflammatory Bowel Diseases*/drug therapy; Adult ; Pregnancy ; Female ; Humans ; Child ; Consensus ; Japan ; Vaccination/adverse effects

Immunosuppressive therapies can affect the immune response to or safety of vaccination in patients with inflammatory bowel disease (IBD). The appropriateness of vaccination should be assessed prior to the initiation of IBD treatment because patients with IBD frequently undergo continuous treatment with immunosuppressive drugs. This consensus was developed to support the decision-making process regarding appropriate vaccination for pediatric and adult patients with IBD and physicians by providing critical information according to the published literature and expert consensus about vaccine-preventable diseases (VPDs) [excluding cervical cancer and coronavirus disease 2019 (COVID-19)] in Japan. This consensus includes 19 important clinical questions (CQs) on the following 4 topics: VPDs (6 CQs), live attenuated vaccines (2 CQs), inactivated vaccines (6 CQs), and vaccination for pregnancy, childbirth, and breastfeeding (5 CQs). These topics and CQs were selected under unified consensus by the members of a committee on intractable diseases with support by a Health and Labour Sciences Research Grant. Physicians should provide necessary information on VPDs to their patients with IBD and carefully manage these patients' IBD if various risk factors for the development or worsening of VPDs are present. This consensus will facilitate informed and shared decision-making in daily IBD clinical practice.
(© 2023. Japanese Society of Gastroenterology.)

Erratum in: J Gastroenterol. 2023 Apr;58(4):431-432. doi: 10.1007/s00535-023-01965-0. (PMID: 36763141)

Lancet Infect Dis. 2017 Mar;17(3):313-321. (PMID: 28126327)
Dig Dis Sci. 2019 Jan;64(1):189-195. (PMID: 30317494)
Obstet Gynecol. 1988 Sep;72(3 Pt 2):459-61. (PMID: 3043294)
Vaccine. 2019 Oct 23;37(45):6793-6802. (PMID: 31562000)
Inflamm Bowel Dis. 2001 Nov;7(4):327. (PMID: 11720324)
Ann Rheum Dis. 2020 Jan;79(1):39-52. (PMID: 31413005)
J Crohns Colitis. 2018 Feb 28;12(3):376-378. (PMID: 29045603)
JAMA. 2012 Jul 11;308(2):165-74. (PMID: 22782418)
MMWR Recomm Rep. 2007 Jun 22;56(RR-4):1-40. (PMID: 17585291)
MMWR Morb Mortal Wkly Rep. 2018 Jan 26;67(3):103-108. (PMID: 29370152)
Lancet Infect Dis. 2021 Feb;21(2):286-295. (PMID: 32888410)
J Infect. 2017 Nov;75(5):448-454. (PMID: 28813644)
J Clin Immunol. 2020 Jan;40(1):24-64. (PMID: 31953710)
J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S429-S442. (PMID: 34590136)
Aliment Pharmacol Ther. 2020 Jan;51(1):129-138. (PMID: 31692017)
Am J Gastroenterol. 2019 Jul;114(7):1130-1141. (PMID: 31205131)
Gut. 2014 Mar;63(3):451-7. (PMID: 23424097)
J Clin Gastroenterol. 2012 Sep;46(8):718-9. (PMID: 22858514)
Inflamm Bowel Dis. 2007 Jun;13(6):759-62. (PMID: 17230540)
Int J Clin Pract. 2015 Feb;69(2):228-34. (PMID: 25363271)
Gut. 2012 Mar;61(3):385-91. (PMID: 21757451)
Intest Res. 2017 Jan;15(1):97-102. (PMID: 28239319)
World J Gastroenterol. 2006 Feb 14;12(6):974-6. (PMID: 16521231)
Inflamm Bowel Dis. 2019 Feb 21;25(3):532-540. (PMID: 30085137)
World J Gastroenterol. 2008 May 28;14(20):3201-6. (PMID: 18506926)
Gastroenterology. 2018 Sep;155(3):696-704. (PMID: 29857090)
Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004876. (PMID: 16856068)
Clin Exp Gastroenterol. 2013 May 06;6:43-9. (PMID: 23818801)
Gut. 2008 Apr;57(4):549-58. (PMID: 18178610)
Gastroenterology. 2019 Apr;156(5):1508-1524. (PMID: 30658060)
Inflamm Bowel Dis. 2015 May;21(5):1089-97. (PMID: 25895005)
J Pediatr (Rio J). 2011 May-Jun 8;87(3):269-72. (PMID: 21461453)
J Pediatr Gastroenterol Nutr. 2012 Jun;54(6):830-7. (PMID: 22584748)
Inflamm Bowel Dis. 2016 Mar;22(3):638-47. (PMID: 26595551)
J Dermatol Sci. 2015 Sep;79(3):235-40. (PMID: 26070505)
Clin Gastroenterol Hepatol. 2007 Jul;5(7):851-6. (PMID: 17544875)
Inflamm Bowel Dis. 2019 Jan 10;25(2):369-376. (PMID: 30020478)
Eur J Gastroenterol Hepatol. 2017 May;29(5):509-515. (PMID: 28350740)
MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34. (PMID: 23760231)
Inflamm Bowel Dis. 2018 Sep 15;24(10):2258-2265. (PMID: 29850873)
N Engl J Med. 2015 May 28;372(22):2087-96. (PMID: 25916341)
Gastroenterology. 2021 Aug;161(2):669-680.e0. (PMID: 33617891)
Birth Defects Res. 2019 Jan 15;111(2):88-95. (PMID: 30623611)
Am J Gastroenterol. 2016 Apr;111(4):577. (PMID: 27125715)
Vaccine. 2018 Jun 7;36(24):3555-3566. (PMID: 28648543)
J Crohns Colitis. 2010 Nov;4(5):603-5. (PMID: 21122568)
Inflamm Bowel Dis. 2021 Jan 1;27(1):e9. (PMID: 33027525)
Vaccine. 2017 Mar 1;35(9):1216-1226. (PMID: 28162821)
Am J Gastroenterol. 2017 Feb;112(2):241-258. (PMID: 28071656)
MMWR Morb Mortal Wkly Rep. 2010 Feb 12;59(5):130-2. (PMID: 20150888)
Br J Clin Pharmacol. 2013 Dec;76(6):988-96. (PMID: 23528073)
Am J Gastroenterol. 2006 Jun;101(6):1390-2. (PMID: 16771965)
Clin Gastroenterol Hepatol. 2013 Mar;11(3):286-92; quiz e24. (PMID: 23200982)
Immunol Rev. 2019 Jan;287(1):162-185. (PMID: 30565237)
Ann Rheum Dis. 2016 May;75(5):795-810. (PMID: 26888948)
Curr Drug Targets. 2010 Feb;11(2):198-218. (PMID: 20210768)
J Crohns Colitis. 2018 Jan 24;12(2):258-261. (PMID: 28961694)
Inflamm Bowel Dis. 2012 Jun;18(6):1042-7. (PMID: 21674732)
J Lab Clin Med. 1989 Jun;113(6):695-9. (PMID: 2732617)
Eur J Epidemiol. 2020 Apr;35(4):371-379. (PMID: 31950373)
Clin Gastroenterol Hepatol. 2006 Dec;4(12):1483-90. (PMID: 17162240)
Best Pract Res Clin Obstet Gynaecol. 2014 Nov;28(8):1163-73. (PMID: 25271063)
Curr Gastroenterol Rep. 2018 Apr 17;20(5):23. (PMID: 29666967)
J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1066-1075. (PMID: 27836056)
J Gastroenterol. 2021 Jun;56(6):489-526. (PMID: 33885977)
Gastroenterology. 2008 Apr;134(4):929-36. (PMID: 18294633)
Travel Med Infect Dis. 2018 Jul - Aug;24:89-100. (PMID: 29860151)
Inflamm Bowel Dis. 2014 Mar;20(3):495-501. (PMID: 24407486)
Gastroenterology. 2016 Jul;151(1):110-9. (PMID: 27063728)
Clin Gastroenterol Hepatol. 2022 Apr;20(4):e653-e663. (PMID: 33746097)
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1341-1347. (PMID: 30326303)
Inflamm Bowel Dis. 2012 Dec;18(12):2392-403. (PMID: 22434654)
J Pediatr. 1974 Sep;85(3):324-8. (PMID: 4372551)
Hepatol Res. 2020 Jul;50(7):791-816. (PMID: 32343477)
Clin Infect Dis. 2021 Aug 16;73(4):726-729. (PMID: 33462610)
J Crohns Colitis. 2014 Apr;8(4):282-7. (PMID: 24067604)
J Pediatr. 1972 Nov;81(5):936-45. (PMID: 5086721)
Gastroenterol Res Pract. 2017;2017:4139656. (PMID: 29075289)
J Infect Dis. 1982 May;145(5):661-6. (PMID: 7077090)
Semin Arthritis Rheum. 2010 Jun;39(6):442-7. (PMID: 19246078)
Epidemiology. 2018 Jan;29(1):107-116. (PMID: 28930786)
J Crohns Colitis. 2014 Jun;8(6):443-68. (PMID: 24613021)
Aliment Pharmacol Ther. 2019 Dec;50(11-12):1181-1188. (PMID: 31617226)
Inflamm Bowel Dis. 2013 Jun;19(7):1441-9. (PMID: 23567780)
J Crohns Colitis. 2018 Jul 30;12(8):948-953. (PMID: 29726943)
World J Gastroenterol. 2017 Nov 14;23(42):7644-7652. (PMID: 29204064)
Gut. 2019 Dec;68(Suppl 3):s1-s106. (PMID: 31562236)
Gastroenterology. 2021 Aug;161(2):681-700. (PMID: 34334167)
Gastroenterology. 2016 Mar;150(3):734-757.e1. (PMID: 26688268)
J Crohns Colitis. 2015 Feb;9(2):107-24. (PMID: 25602023)
Autoimmun Rev. 2011 Dec;11(2):112-22. (PMID: 21896342)
Aliment Pharmacol Ther. 2018 Aug;48(3):386-388. (PMID: 29998502)
Vaccine. 2009 Oct 9;27(43):5974-81. (PMID: 19679215)
J Pediatr. 2016 Apr;171:140-5. (PMID: 26826886)
Clin Vaccine Immunol. 2006 Apr;13(4):437-43. (PMID: 16603610)
Am J Gastroenterol. 2004 Dec;99(12):2503-4. (PMID: 15571606)
Digestion. 2021;102(6):956-964. (PMID: 33971650)
Inflamm Bowel Dis. 2010 Jun;16(6):916-24. (PMID: 19885908)
Clin Vaccine Immunol. 2010 Jul;17(7):1055-65. (PMID: 20463105)
J Gastroenterol Hepatol. 2015 Jan;30(1):92-8. (PMID: 25160690)
Gut. 2010 Oct;59(10):1340-6. (PMID: 20577000)
Dig Dis Sci. 2011 Mar;56(3):819-24. (PMID: 20668942)
Eur J Clin Microbiol Infect Dis. 2020 Feb;39(2):219-227. (PMID: 31650411)
Inflamm Bowel Dis. 2012 Nov;18(11):2004-10. (PMID: 22337144)
J Crohns Colitis. 2011 Dec;5(6):555-8. (PMID: 22115374)
Lupus. 2019 Jul;28(8):1027-1028. (PMID: 31126211)
Arthritis Rheumatol. 2020 Apr;72(4):529-556. (PMID: 32090480)
J Dermatol Sci. 2013 Mar;69(3):243-9. (PMID: 23183011)
J Gastroenterol. 2015 Aug;50(8):876-86. (PMID: 25672513)
Inflamm Bowel Dis. 2019 Mar 14;25(4):789-796. (PMID: 30239799)
PLoS One. 2020 Oct 1;15(10):e0240217. (PMID: 33002085)
Clin Gastroenterol Hepatol. 2018 Jan;16(1):99-105. (PMID: 28870657)
J Pediatr. 2018 May;196:217-222.e1. (PMID: 29499990)
J Crohns Colitis. 2021 Jun 22;15(6):879-913. (PMID: 33730753)
J Infect Dis. 2018 May 5;217(11):1750-1760. (PMID: 29529222)
Inflamm Bowel Dis. 2018 Apr 23;24(5):1082-1091. (PMID: 29538682)
Scand J Infect Dis. 1973;5(4):237-41. (PMID: 4798559)
N Engl J Med. 2007 Mar 29;356(13):1338-43. (PMID: 17392303)
Am J Gastroenterol. 2012 Oct;107(10):1460-6. (PMID: 23034605)
Inflamm Bowel Dis. 2016 Jun;22(6):1391-6. (PMID: 27057679)
Inflamm Bowel Dis. 2019 Nov 14;25(12):1966-1973. (PMID: 31067308)
Vaccine. 2017 Jan 23;35(4):521-528. (PMID: 28024955)
Inflamm Bowel Dis. 2012 Jan;18(1):25-33. (PMID: 21472826)
Obstet Gynecol. 2018 Apr;131(4):e109-e114. (PMID: 29578985)
Am J Gastroenterol. 2013 Feb;108(2):240-8. (PMID: 23295276)
JAMA. 2010 Apr 21;303(15):1517-25. (PMID: 20407061)
Clin Gastroenterol Hepatol. 2011 Jan;9(1):30-5. (PMID: 20951835)
Inflamm Bowel Dis. 2020 Aug 20;26(9):1407-1414. (PMID: 31689349)
Pediatr Int. 2007 Jun;49(3):418-9. (PMID: 17532851)
BMC Gastroenterol. 2011 Jul 29;11:87. (PMID: 21798078)
Vaccine. 2021 Jul 5;39(30):4199-4202. (PMID: 34140170)

20316729 Ministry of Health, Labour and Welfare

Keywords: Crohn’s disease; Immunization; Ulcerative colitis; Vaccine-preventable disease

Date Created: 20230111 Date Completed: 20230127 Latest Revision: 20240912

20240912

PMC9838549

10.1007/s00535-022-01953-w

36629948